WO2010003327A1

WO2010003327A1 - Vision-improving instrument for curing ophthalmological visual obstruction disease

Info

Publication number: WO2010003327A1
Application number: PCT/CN2009/071099
Authority: WO
Inventors: 李隆献
Original assignee: 李绍极; 周永耀
Priority date: 2008-07-08
Filing date: 2009-03-31
Publication date: 2010-01-14
Also published as: CN101322867A

Abstract

A vision-improving instrument for curing ophthalmological visual obstruction disease is provided. The vision-improving instrument comprises an electrical pulse generator (10) for producing electrical pulse which could trigger visual excitation of the patient and generate visual effect by conveying visual information, a pair of electrode plates (20) and medical plaster (30). The electrical pulse generator (10) is connected to the electrode plates (20) by conducting wire (15). The electrical pulse produced by the electrical pulse generator (10) is conducted to the medical plaster (30) through electrode plate (20). The medical plaster (30) filled with the medical solution for curing ophthalmological visual obstruction disease.

Description

Intensive vision device for treating ophthalmic visual impairment disorders

[1] Technical field

[2] The present invention relates to an ophthalmic medical instrument for treating visual eye disorders in combination with Chinese medicine and modern medicine

In particular, it relates to a visual acuity device for treating amblyopia, glaucoma, etc., optic neuropathy, early optic atrophy, senile visual deterioration, early senile cataract, and other ophthalmic visual impairment diseases.

[3] Background Art

[4] At present, the incidence of amblyopia in the population, especially among children and adolescents, is relatively high, which brings more troubles to the amblyopic patients themselves and their families. There are many treatments for amblyopia, such as occlusion therapy, fine eyesight training

, various comprehensive treatments, etc., regardless of which one, there are shortcomings of cure rate, especially in severe treatment rate of less than 17%, and long course of treatment.

[5] With the improvement of the national health care industry, people's life expectancy is prolonged, and senile cataract, glaucoma and optic atrophy become common diseases of middle-aged and elderly people, and they are also distributed in other populations. At present, the senile cataract in the mature stage is mainly recovered by surgery, and there is no effective treatment for immature senile cataract, glaucoma and optic atrophy.

[6] Summary of the invention

[7] The object of the present invention is to provide an eye-viewing device for treating ophthalmologic visual impairment diseases, which can effectively treat amblyopia in children and adolescents, and has an eye-enhancing effect on eye diseases such as cataract, glaucoma and optic atrophy, and Eye care.

[8] The technical scheme of the present invention is: A vision device for introducing a Chinese medicine liquid into the treatment of an ophthalmic visual impairment disease, which comprises - for generating an electric pulse capable of exciting a patient's visual excitement and visual information transmission to produce a visual effect a generating device, a pair of electrode plates, and a drug application device, wherein the electric pulse generating device is connected to the electrode plate through a wire, and the electric pulse generated by the electric pulse generating device is transmitted to the drug application through the electrode plate; A liquid medicine for treating eye diseases of the eye.

[9] The technical solution is further explained below:

[10] The generating device generates a plurality of harmonics generated after the electric pulse of the visual excitatory pulse information wave is modulated by a square wave of two different pulse frequencies, and one of the two square wave pulses is a chirped square wave pulse Frequency The range is 35~: ΙΟΟΗζ, the other is a high-frequency square wave pulse, the frequency range is 3500~4500Hz, and two square wave pulse modulations generate multiple harmonics of 35~4500Hz. As a preferred solution: the frequency range of the 1 氐 square wave pulse in the two square wave pulses is 35~: ΙΟΟΗζ, the frequency range of the high frequency square wave pulse is 35 00~4000 Hz, and two square wave pulse modulations are generated. Multiple harmonics of 35~4000Hz. As a more preferable scheme, the frequency of the chirped square wave pulse in the two square wave pulses is 35 Hz, and the frequency range of the high frequency square wave pulse is 4000 Hz.

[11] The turns generated by the electrical pulse can be set as needed.

[12] The application of the drug application can be made of non-woven fabric or gauze.

[13] The drug solution is an appetizer soup, which is based on an eye disease that causes visual impairment, especially for severe amblyopia and irreversible visual impairment of a child with a cure rate of sputum, primary open angle glaucoma, optic neuropathy, optic atrophy, Pathological pathogenesis of diseases such as dysfunction of the elderly, and the pharmacological effects of modern Chinese medicine ingredients, combined with more than 30 years of clinical practice, to form a therapeutic prescription: consisting of ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus . The combination of Rehmannia glutinosa and Radix Rehmanniae has nourishing liver and kidney, nourishing essence and nourishing blood, to ensure that the Shenguang hair is more active, and the liver and eyesight are combined with chrysanthemum; Danshen activating blood circulation and removing blood stasis, Tongli meridian; ginseng is the force of qi The biggest, the blood is the blood, so that the essence of the kidney water is focused on the eyes, it can be regarded as everything, empty and endless. This prescription has unique curative effect on the treatment of ophthalmopathy of visual acuity, such as neurons, visual pathways, and visual center, which are inhibited by amblyopia, optic neuropathy, optic atrophy, visual aging, and depression.

[14] For the treatment of open-angle glaucoma, the preparation of the drug solution includes ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus, safflower, puerarin, piglet, the same amount of raw materials The dose is formulated to contain 2 to 4% of the water by weight of the medicinal material. The irreversible damage mechanism of visual acuity caused by glaucomatous optic ganglion cell damage has been revealed as early as 20 years ago, and no effective reversible treatment has been found. The use of the present invention to introduce the active ingredients such as Salvia miltiorrhiza, Radix Puerariae, and Safflower into the eye, promoting blood circulation, dilating blood vessels, and facilitating the meridians, which can effectively lower the intraocular pressure (exceeding the effect of timolol). The most powerful ginseng combination, Yiqihuoxue reduces blood viscosity, accelerates blood flow, and effectively improves the microcirculation of the retina, thereby preventing the release of neuromuscular toxins caused by ischemia and hypoxia, accompanied by harmful ion overload, etc. The formation of a vicious circle of ganglion cell damage, resulting in irreversible damage to visual function. Because of the scientific and unique treatment principle and function, this new treatment of the monitor effectively prevents the retinal ischemia from causing the visual network. In situ death of membrane ganglion cells restores useful vision and even restores its normal visual function.

[15] For visual impairment caused by early cataract in the elderly, neuron reduction in the elderly, and decreased neurotransmission, the preparation of the drug solution includes ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum , Acorus calamus, Ganoderma lucidum, Dendrobium, the above raw materials are prepared in equal amounts of 2~4% water containing the weight of the drug. Under the action of Ganoderma lucidum polysaccharides, it enhances the anti-aging effect, and in combination with ginseng and medlar, it increases the activity of DNA polymerase α in cells, thereby promoting cell proliferation and division; ginseng, medlar, Ganoderma lucidum and Dendrobium synergistically strengthen Anti-oxygen free radical action, effectively scavenging oxygen damage to tissue damage. Together with the pulse information wave generated by the viewer, the alternating current signal and the voltage amplitude, it promotes the ion and small molecule transmembrane movement, tissue material transport and substance exchange of the eye tissue cells, thus preventing the ions from being Pathological retention in the cells. The above drugs are introduced into the eye through a visual acuity device, which promotes the synthesis of nucleic acid proteins in the body, enhances cell division and metabolism, revitalizes cells that are originally in apoptosis and close to apoptosis, and restores their physiological functions, thereby improving visual acuity.

[16] After the application of medicinal application, the traditional Chinese medicine solution of the specific formula is prepared. The preparation process of the traditional Chinese medicine liquid is: slicing, washing, soaking for 30 minutes, boiling (small simmer), slag removal, filtration, Concentrate to 1%, prepare, canning (cans must be cleaned, disinfected, sterile), and stored at room temperature. Then make the application, the production process is: soaking, packaging, steam sterilization in the liquid medicine with non-woven fabric or gauze.

[17] The electrode plate (including the wire) in the viewer of the present invention is used to introduce an electric pulse generated by the electric pulse generating device onto the drug application patch, and the electrode plate should also be firmly fixed to the eyelid in the closed eye state. On the skin surface, the eye mask and other devices are used to secure the electrode plate and the drug patch to the eye.

[18] The advantages of the invention are:

[19] 1. The visual acuity device for treating ophthalmic visual impairment disease of the present invention has the characteristics of short treatment course and remarkable curative effect for treating amblyopia, for example, the general treatment of mild amblyopia with the visual acuity device of the present invention is generally required. In 10 days, the recovery rate is generally ₉₆ %. It usually takes 40 days to treat moderate amblyopia. The recovery rate is generally 86%. It usually takes 120 days to treat severe amblyopia. The recovery rate is generally 70%. In addition, the spectator of the present invention has an eye-imaging effect on eye diseases such as cataract, glaucoma, and optic atrophy, and can also serve as an eye care for normal eyes.

[20] 2. The visual acuity device for treating ophthalmic diseases of the present invention can generate visual nerve excitation pulse information waves, can effectively stimulate sufficient visual excitability, visual information transmission, and produce visual effects. [21] 3. The eye-viewing device for treating ophthalmic visual impairment disease of the invention has the function of introducing drugs into the body: the pulse current which belongs to the one-way alternating change occurred by the sight-increasing device, and there is no positive and negative electrode, in the medicine Both positive and negative ions can be introduced, even larger molecules can be introduced, and the introduction amount is deeper and deeper.

[22] 4. The visual acuity device for treating ophthalmic visual impairment disease of the present invention improves local blood circulation, increases the number of open capillaries, and accelerates blood flow. Plus drugs (such as salvia miltiorrhiza, safflower) to promote blood circulation, dilate blood vessels, reduce blood viscosity, accelerate blood flow, can effectively improve the microcirculation of the retina.

[23] 5. The visual acuity device for treating ophthalmic visual impairment disease of the present invention has the physiological action of pulse electricity: under the action of alternating pulse electrical signals and voltage amplitude, promoting the electrical activity of the ocular tissue cells, ions And small molecules transmembrane movement, thereby enhancing the transport and exchange of substances in the tissue, preventing the pathological retention of ions in the cells. In addition, the metabolism of the body is enhanced, which promotes the synthesis of nucleic acid in the body, and the cell division, reviving the cells that are originally in apoptotic and near-apoptotic, and restoring their physiological functions.

[24] 6. The visual acuity device for treating ophthalmic visual impairment disease of the invention has the function of electro-acupuncture-like effect: the pulse wave modulated by the visual acuity meter is applied to the acupoints of the eyesight by the contrast-enhancing medium, like countless Electroacupuncture-like effects cause eye plant nerves to excite, promote eye blood circulation, and increase metabolism.

[25] 7. The visual acuity device for treating ophthalmic visual impairment diseases of the present invention, which is used for treating visual impairment, has the characteristics of short treatment course and remarkable curative effect.

[26] BRIEF DESCRIPTION OF THE DRAWINGS

[27] The present invention will be further described below in conjunction with the accompanying drawings and embodiments:

[28] FIG. 1 is a schematic structural view of the present invention;

2 is a schematic block diagram of an electric pulse generating device of the present invention.

[30] wherein: 10 electric pulse generating device; 11 oscillating pulse generating circuit; 12 oscillating pulse amplifying output circuit;

13 fixed control circuit; 14 DC voltage regulator circuit; 15 wires; 20 electrode plate; 30 drug application.

[31] Detailed implementation

[32] Example 1:

[33] As shown in Fig. 1, a visual acuity apparatus for treating an ophthalmic disease includes an electric pulse generating device 10, a pair of electrode plates 20, and a drug application patch 30. The electric pulse generating device 10 is connected to the electrode plate 20 via a wire 15, and an electric pulse generated by the electric pulse generating device 10 is introduced into the dipping applicator 30 through the electrode plate 20. Use 吋, will be dipped The drug application patch 30 for treating the corresponding ophthalmic disease is applied to the surface of the eyelid in the closed state, and then the two positive and negative electrode plates 20 are placed thereon, and the positive and negative ions of the drug can be introduced into the body part, thereby fully exerting The role of drugs to promote the body's recovery.

As shown in Fig. 2, the electric pulse generating device 10 includes an oscillation pulse generating circuit 11, an oscillation pulse amplifying output circuit 12, a fixed-turn control circuit 13, and a DC voltage stabilizing circuit 14.

[35] The electric pulse generated by the oscillation pulse generating circuit 11 is a multiple harmonic generated after modulating a square wave of two different pulse frequencies, and one of the two square wave pulses is a 1 氐 square wave pulse, and the frequency range is 35 Hz. The other is a high-frequency square wave pulse with a frequency range of 4000 Hz. After two square wave pulse modulation, 35~4000 is generated.

Multiple harmonics of Hz.

[36] In order to achieve the therapeutic effect, the oscillation pulse amplification output circuit 12 amplifies the weak pulse information to 0 to 15 V, and the current density of the electrode plate 20 is 0 to 0.66 mA/cm ² . It is then fed onto the electrode plate 20.

[37] For the needs of treatment, the intensity of the pulse can be controlled to adapt to the needs of different individuals, so the above signal is sent to the oscillation pulse amplification output circuit 12, and the weak pulse signal is amplified by the oscillation pulse amplification output circuit 12 100~1000mV, coupled to the positive and negative electrode plates 20 of the visual augmentation device, so that alternating pulse information acts on the eye, which will effectively promote visual excitement and transmit to the visual center of the brain to form vision. If you are here, apply a drug solution that is immersed in the treatment of the corresponding disease (such as Zengshitang containing Chinese herbs such as medlar, chrysanthemum, ginseng, and salvia) to the surface of the eyelid that is slightly closed, and then By placing two electrode plates on it, the drug can be introduced into the eye to fully exert the drug's action and promote the body's recovery.

[38] The fixed control circuit 13 is used to control the operation time of the oscillation pulse generating circuit 11, so that the treatment time of the visual acuity can be controlled according to the needs of the treated ophthalmic disease.

[39] The viewer of the present embodiment can provide stable DC power supply to the oscillation pulse generating circuit 11, the oscillation pulse amplifying output circuit 12, and the fixed-loop control circuit 13 by using 3.6 V DC.

[40] The application of the drug patch 30 is a non-woven application. The medicine application 30 contains a liquid medicine for treating different medical components of various eye diseases with different visual impairments. In this embodiment, the preparation medicine for the diarrhea soup contains ginseng, medlar, dodder, rehmannia, chrysanthemum and salvia , Acorus calamus, the above bulk drug is formulated into an amount of 4% water containing the weight of the drug, which can be used to treat amblyopia in children and adolescents, degeneration of optic function, optic atrophy, and for vision care. The dip applicator 30 is applied to the eye to be treated using a crucible, the electrode plate 20 is pressed against the applicator, the switch of the electric pulse generating device 10 is turned on, and the intensity of the electric pulse is adjusted in a personal situation. In addition, the electrode plate 20 and the drug application patch 30 are fixed to the closed eyelid by actually wearing an eye mask or other means.

[41] Example 2:

[42] The difference between this embodiment and the first embodiment is that: the preparation of the drug solution comprises ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus, safflower, puerarin, piglet, the above raw materials The equivalent dose is formulated into a 4% aqueous solution containing the weight of the medicinal material and can be used to treat open angle glaucoma.

[43] Example 3:

[44] The difference between this embodiment and the first embodiment is that: the preparation of the drug solution comprises ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus, ganoderma lucidum, sarcophagus, the above raw materials are equivalent The dose is formulated as a 2% aqueous solution containing the weight of the medicinal material and can be used to treat early senile cataracts.

[45] Experimental example:

[46] Amblyopia teenager Feng Moumou, male, 13 years old, Liantang people in Gaoyao County, first diagnosed on August 4, 2007. After comprehensive treatment for half a year, after treatment, he was treated with the microscope of the present invention.

[47] The visual acuity of the anterior eye with a monitor is: right eye visual acuity 1.5; left eye uncorrected visual acuity 0.04, corrected visual acuity 0.1, refractive state +3.5DS, astigmatism +0.75DCxl00°.

[48] After nearly 4 and a half months of visual acuity treatment, on January 1, 2008, the results were as follows: Left eye naked eye vision recovered to 1.0, corrected visual acuity 1.5.

[49] Of course, the present invention for treating ophthalmic visual impairment diseases can also have various transformations and modifications.

It is not limited to the specific structure of the above embodiment. In conclusion, the scope of the present invention should include such modifications or substitutions and modifications as would be apparent to those skilled in the art.

Claims

Claim

A visual acuity device for treating an ophthalmologic visual impairment disorder, comprising: an electric pulse generating device (10) for generating a visual effect capable of exciting a patient's visual excitement and visual information transmission, and a pair of electrodes a plate (20), and a drug application (30), the electrical pulse generating device (10) is connected to the electrode plate (20) through a wire (15), and an electrical pulse generated by the electrical pulse generating device (10) passes through the electrode plate (30) The drug application (30) is contained on the drug application patch (30), and contains a drug solution for treating a medical component of an eyesight disorder.

2. The spectator for treating an ocular visual impairment according to claim 1, wherein: the electric pulse generated by the electric pulse generating device (10) is modulated by two square waves of different pulse frequencies. The generated multiple harmonics, one of the two square wave pulses is a chirped square wave pulse, the frequency range is 35~: ΙΟΟΗζ, and the other is a high frequency square wave pulse, the frequency range is 3500~450 0Hz, two After the square wave pulse modulation, multiple harmonics of 35~4500 Hz are generated.

3. The spectator for treating an ophthalmic disease according to claim 2, wherein: the low frequency square wave pulse frequency range of the two square wave pulses is 35 to 100 Hz, and the high frequency square wave pulse frequency range For 3500~4000Hz, two square wave pulse modulations generate multiple harmonics of 35~4000Hz.

4. The spectator for treating an ocular disorder according to claim 2, wherein: the frequency range of the chirped square wave pulse in the two square wave pulses is 35 Hz, and the high frequency square wave pulse frequency The range is 4000 Hz.

The visual acuity device for treating an ophthalmologic visual impairment according to claim 1, wherein: the diurnal generated by the electric pulse can be set as needed.

The visual acuity device for treating an ophthalmologic visual impairment according to claim 1, wherein the application of the medical application (30) is a non-woven application.

7. The spectator for treating an ocular visual impairment according to claim 1, wherein the application of the drug application (30) is a gauze application.

The visual acuity device for treating an ophthalmologic visual impairment according to claim 1, wherein: the preparation medicine for the medical liquid comprises ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus The above raw materials are formulated into equal amounts of 2~4% water agent containing the weight of the medicine. It can be used to treat amblyopia in children and adolescents, degeneration of visual function in the elderly, optic atrophy, and use in vision care.

9. The spectator for treating an ocular disorder according to claim 1, wherein: the preparation of the medicinal solution comprises ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus , safflower, puerarin, piglet, the above raw materials are prepared in equal amounts of 2~4% water containing the weight of the medicine, which can be used for the treatment of open angle glaucoma.

10. The spectator for treating an ocular disorder according to claim 1, wherein: the preparation of the medicinal solution comprises ginseng, medlar, rehmannia, dodder, salvia, chrysanthemum, calamus Ganoderma lucidum and Dendrobium can be used to treat early senile cataract with equal doses of 2~4% water containing the weight of the drug.